Landscapes / Targets

S1PR

5 drugs act on S1PR, in 9 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs5

DrugHow it worksCompanyStageNext dateDetails
Sphingosine 1-phosphate receptor modulator
Vanda Pharmaceuticals +1
Approved Aug 2028Phase 3 trial completes
Sphingosine 1-phosphate receptor modulator
Approved 29 Dec 2028Phase 4 trial completes
Sphingosine 1-phosphate receptor modulator
Novartis · Public NVS
Approved —
Sphingosine 1-phosphate receptor modulator
Novartis · Public NVS
Approved —
—
Phase 3 May 2027Phase 3 trial completes

About this list

Checked
5 of 5 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow S1PR

Following is part of Solo: you see every change to S1PR the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in